drugset / Trial / NCT02118376

Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status

NCT02118376

Unknown 20 enrolled Shanghai 10th People's Hospital
NaSingle-groupOpen-labelTreatment

Summary

GLP-1 receptor agonists promote fat redistribution in obese women with type 2 diabetes, reduce liver fat content, improve the inflammation state

Timeline

Start
2014-08
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Exenatide Peptide 5 ug Subcutaneous

Indications